DC
SGMO

Deere & Company’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Deere & Company’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-42,815
Closed -$475K – 1031
2015
Q2 		$475K Buy
42,815
+14,729
+52% +$190K 0.03% 664
2015
Q1 		$440K Hold
28,086
– – 0.02% 679
2014
Q4 		$427K Buy
28,086
+12,987
+86% +$158K 0.02% 685
2014
Q3 		$163K Hold
15,099
– – 0.01% 927
2014
Q2 		$231K Buy
+15,099
New +$217K 0.01% 803
2014
Q1 		– Sell
-34,285
Closed -$476K – 1038
2013
Q4 		$476K Sell
34,285
-6,695
-16% -$77.1K 0.02% 673
2013
Q3 		$430K Buy
40,980
+16,698
+69% +$166K 0.02% 691
2013
Q2 		$190K Buy
+24,282
New +$212K 0.01% 881

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Deere & Company's SGMO Position: Q3 2015 in Review

Deere & Company sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2015, closing a stake of 42,815 shares — an estimated $475K sold.

Deere & Company first reported a position in SGMO in Q2 2013 and held it in 8 quarters. The position peaked at $476K in Q4 2013. 141 funds tracked by Wall St. Rank hold SGMO as of Q3 2015.

  • Deere & Company reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 42,815 SANGAMO THERAPEUTICS INC shares in Q3 2015, an estimated $475K.
  • Deere & Company first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and held it in 8 quarters.
  • Deere & Company's SANGAMO THERAPEUTICS INC position peaked at $476K in Q4 2013.
  • 141 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.